David Johnson

Running Back

Age: 30
Free Agency: 2022 (UFA)
Accrued Seasons: 6
  • 2021 Salary Cap Charge: $4,779,412 (2.47% of cap)
  • 2021 Cash Payout: $5,000,000 (2.36% of spending)
  • 2021 Cash to Cap Ratio: 1.05
  • Contract Value: $5,000,000 ($5,000,000 APY)
  • Fully Guaranteed Money: $4,250,000
  • Contract Ranking: 15/153 at RB

Current Contract

(Other, signed 2021)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated BonusPer Game Roster BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202130$1,250,000$3,000,000$750,000$1,250,000$4,779,4122.5%
Total$1,250,000$3,000,000$750,000$1,250,000$4,779,412

Contract Notes

David Johnson signed a revised 1 year contract with the Houston Texans on March 10, 2021. Contract base value is $5 million with $4.25 million guaranteed, and includes $750,000 in roster bonuses (paid $46,875 per game active). Johnson can earn an additional $2 million through incentives based on performance. The revised contract generated $3.7 million in initial cap savings for Houston.

Cash Flows

- fully earned money
- unearned or partially earned money
$5M
2021
Cash Due$5,000,000
Running Cash$5,000,000
Career Earnings: $36,564,622
Career APY: $6,094,104
Potential Earnings: $38,564,622
Total Guarantees: $54,254,372
Largest Cash Payment: $13,882,500 (2018)
Largest Cap Number: $11,156,250 (2020)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
CardinalsDraftedRenegotiated20154$2,992,872$748,218$639,372$2,263,37275.6%$754,457
TexansExtensionRenegotiated20183$39,000,000$13,000,000$24,682,500$10,762,50027.6%$10,762,500
CardinalsExtensionTraded20183$39,000,000$13,000,000$24,682,500$20,538,75052.7%$10,269,375
TexansOtherActive20211$5,000,000$5,000,000$4,250,000$3,000,00060.0%$0
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Cardinals5$22,802,122$4,560,424$16,895,3720.0%$6,000,0000.0%
Texans1$13,762,500$13,762,500$11,156,2500.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusRoster BonusPer Game Roster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2015Cardinals$435,000$159,843$0$0$0$0$594,8430.4%$1,074,372
2016Cardinals$525,000$159,843$0$0$24,000$0$708,8430.4%$549,000
2017Cardinals$615,000$159,843$0$0$25,000$0$799,8430.5%$640,000
2018Cardinals$1,882,500$3,159,843$0$0$0$1,882,500$5,041,8432.8%$13,882,500
2019Cardinals$5,700,000$3,000,000$300,000$750,000$0$5,700,000$9,750,0005.0%$6,656,250
2020Texans$10,200,000$0$300,000$750,000$0$10,200,000$11,156,2505.1%$10,762,500
2021Texans$1,250,000$3,000,000$0$750,000$0$1,250,000$4,779,4122.5%$5,000,000
Total$20,607,500$9,639,372$600,000$2,250,000$49,000$19,032,500$32,831,034$38,564,622
Dead Money History
TeamYearCap ChargeCash Paid
Cardinals2020$6,000,000$0
Total$6,000,000$0

Statistics

YearGames PlayedGames MissedSnapsRushingReceivingFumbles
InjuredHealthyOffenseSpecialAttYardsAvgTDRecYardsAvgTDTotalLost
2015160037.5%24.6%1255814.683645712.7441
2016160083.8%0.2%29312394.2168087911.0453
201711504.1%0.0%11232.1066711.2021
2018130063.7%0.0%2589403.67504468.9332
2019132041.8%0.2%943453.723637010.3411
2020120556.1%0.0%1476914.76333149.5200

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$5,113,000$5,000,000
Injury Adjusted$5,113,000$5,000,000
test
OTC Valuation $2.6M $5.2M $7.8M $10.5M $13.1M APY $2.7M $5.3M $8.0M $10.7M $13.3M $6,038,000 $3,600,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.